Alignment of receptor nomenclature with the human genome: Classification of 5-HT1B and 5-HT1D receptor subtypes

Trends in Pharmacological Sciences

Volumn 17, Issue 3, 1996, Pages 103-105

  Hartig, Paul R ^a   Hoyer, Daniel ^b   Humphrey, Patrick P A ^c   Martin, Graeme R ^d  

^a DUPONT COMPANY   (United States)

^b Preclinical Research   (Switzerland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ION CHANNEL; RECEPTOR SUBTYPE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1DALPHA RECEPTOR; SEROTONIN 1DBETA RECEPTOR; UNCLASSIFIED DRUG;

CLASSIFICATION; DOG; GENOME; HUMAN; NOMENCLATURE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SHORT SURVEY; SPECIES DIFFERENCE;

ANIMALS; GENOME, HUMAN; HUMANS; RECEPTORS, SEROTONIN; TERMINOLOGY;

EID: 0029930933     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)30002-3     Document Type: Note

References (22)

1. Kenakin, T. P., Bond, R. A. and Bonner, T. I. (1992) Pharmacol. Rev. 44, 351-361
2. Watson, S. P. and Girdlestone, D. (1994) Trends Pharmacol. Sci. 16, 15-16
3. Hoyer, D. et al. (1994) Pharmacol. Rev. 46, 157-203
4. Humphrey, P. P. A., Spedding, M. and Vanhoutte, P. M. (1994) Trends Pharmacol. Sci. 15, 203-204
5. Vanhoutte, P. M., Humphrey, P. P. A. and Spedding, M. Pharmacol. Rev. (in press)
6. Milligan, G. (1993) Trends Pharmacol. Sci. 14, 239-244
7. Boddeke, H. W. G. M., Fargin, A., Raymond, J. R., Schoeffter, P. and Hoyer, D. (1992) Naunyn-Schmied. Arch. Pharmacol. 345, 257-263
8. Adham, N., Vaysse, P. J., Weinshank, R. L. and Branchek, T. A. (1994) Neuropharmacology 33, 403-410
9. Spengler, D. et al. (1993) Nature 365, 170-175
10. Carey, J., Hamilton, J. O'C., Flynn, J. and Smith, G. (1995) Business Week, May 8, 72-78
11. Hartig, P. R., Branchek, T. A. and Weinshank, R. L. (1992) Trends Pharmacol. Sci. 13, 152-159
12. Hamblin, M. W. et al. (1992) Mol. Cell. Neurosci. 3, 578-587
13. Jin, H. et al. (1992) J. Biol. Chem. 267, 5735-5738
14. Parker, E. M., Grisel, D. A., Iben, L. G. and Shapiro, R. A. (1993) J. Neurochem. 60, 380-383
15. Hall, J. M., Caulfied, M. P., Watson, S. P. and Guard, S. (1993) Trends Pharmacol. Sci. 14, 376-383
16. Oksenberg, D. et al. (1992) Nature 12, 161-163
17. Connor, H. E. et al. (1995) Cephalalgia 15 (Suppl. 14), 99
18. Mills, A. and Martin, G. R. (1995) Eur. J. Pharmacol. 280, 175-178
19. Palacios, J. M., Waeber, C., Bruinvels, A. T. and Hoyer, D. (1992) Mol. Brain Res. 13, 175-178
20. Macor, J. E. et al. (1990) J. Med. Chem. 33, 2087-2093
21. Pauwels, P. J. and Palmier, C. (1994) Neuropharmacology 33, 67-75
22. Koe, B. K., Lebel, L. A., Fox, C. B. and Macor, J. E. (1992) J. Neurochem. 58, 1268-1276